As on date of
publishing, this report will capture the impact assessment of COVID-19 on this
market and the same will be considered in our market forecast model. Clients
purchasing this report between April and June 2020 will be getting a ‘free’
updated market data excel sheet between July and September 2020 accounting for
the impact of COVID-19 on the market in the current year 2020 and forecast.
United States infectious disease
biomarker testing market is expected to witness double digit CAGR during the
forecast period. Key factors propelling the growth of United States infectious
disease biomarker testing market include growing
demand for novel molecular diagnostics testing tools due to increasing cases of
coronavirus and presence of leading market players in the country.
Furthermore, frequent outbreak
of various infectious diseases is also acting as a major growth driver for this
market. The presence of highly developed healthcare system coupled with
increasing fund by government for R&D activities in biomarker testing is
augmenting the growth of United States infectious disease
biomarker testing market. Additionally, advancements in molecular
techniques and growth in the biomarker identification market are also expected
to drive the United States infectious disease biomarker testing market through
2025.
United States infectious disease
biomarker testing market can be categorized based on product, application, technology,
pathogen, end user and region. Based on technology, the market can be segmented
into PCR, NGS, ELISA or EIA, IHC, ISH and others. Among these, PCR dominated
the market in 2019 due to high popularity and adoption of PCR based products
compared to other technologies. However, NGS technology is expected to witness fastest
growth during the forecast period owing to the decreasing prices of NGS-based
tests.
Based on end user, United States
infectious disease biomarker testing market can be segmented into hospitals and
clinics, diagnostic centers, research laboratories and others. Among them, hospitals
and clinics segment is anticipated to undergo high growth in terms of revenue
through 2025 as they have laboratories equipped with fully automated diagnostic
instruments including NGS and PCR for providing better medical diagnostic
results.
Major players operating in the United
States infectious disease biomarker testing market include Abbott Laboratories,
Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad
Laboratories, Inc., Danaher Corporation, Hologic, Inc., PerkinElmer, Inc.,
Thermo Fisher Scientific, Inc., Hoffmann-La Roche Inc., Quest Diagnostics
Incorporated and Qiagen Sciences, Inc., among others. The market players are undergoing
partnerships and alliances to strengthen their business position in United States.
Years
considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
- To analyze and estimate the market size of United States infectious
disease biomarker testing market from 2015 to 2018.
- To estimate and forecast the market size of United States infectious
disease biomarker testing market from 2019 to 2025 and growth rate until
2025.
- to classify and forecast United States infectious disease biomarker
testing market based on product, application, technology,
pathogen, end user, company
and regional distribution.
- To identify dominant region or segment in the United States infectious
disease biomarker testing market.
- To identify drivers and challenges for United States infectious
disease biomarker testing market.
- To examine competitive developments such as expansions, mergers
& acquisitions, etc., in United States infectious disease biomarker
testing market.
- To conduct pricing analysis for United States infectious disease
biomarker testing market.
- To identify and analyze the profile of leading players operating in
United States infectious disease biomarker testing market.
- To identify key sustainable strategies adopted by market players in
United States infectious disease biomarker testing market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of infectious disease biomarker testing system manufacturers across United States.
Subsequently, TechSci Research conducted primary research surveys with the
identified companies. While interviewing, the respondents were also enquired
about their competitors. Through this technique, TechSci Research could include
the manufacturers who could not be identified due to the limitations of
secondary research. TechSci Research analyzed the presence of all major players
across United States.
TechSci
Research calculated the market size of United States infectious disease biomarker testing market using a
bottom-up approach, wherein data for various end-user segments was recorded and
forecast for the future years. TechSci Research sourced these values from the
industry experts and company representatives and externally validated through
analyzing historical data of these services and end users for getting an
appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor presentations
and financial reports were also studied by TechSci Research.
Key Target Audience:
- Infectious disease biomarker testing system manufacturers,
suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities
and policy makers
- Organizations, forums and alliances related to
infectious disease biomarker testing
- Market research and consulting firms
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as infectious disease
biomarker testing system manufacturers,
suppliers, partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, United States infectious
disease biomarker testing market has been segmented into following categories,
in addition to the industry trends which have also been detailed below:
- United States Infectious Disease Biomarker Testing Market,
By Product:
- United States Infectious Disease Biomarker Testing
Market, By Application:
- Respiratory
Infection
- Sexually
Transmitted Infection
- Bloodstream
and Hospital-Acquired Infection
- Urinary
Tract Infection
- Gastro-Intestinal
Infection
- Central
Nervous System Infection
- Others
- United States Infectious Disease Biomarker Testing
Market, By Technology:
- PCR
- NGS
- ELISA or
EIA
- IHC
- ISH
- Others
- United States Infectious Disease Biomarker Testing
Market, By Pathogen:
- Virus
- Influenza
- HIV-AIDS
- Hepatitis
- HPV
- Others
- Bacteria
- Tuberculosis
- CT/NG
- Hospital-Acquired
Infection
- Others
- United States Infectious Disease Biomarker Testing
Market, By End User:
- Hospitals
and Clinics
- Diagnostic
Centers
- Research
Laboratories
- Others
- United States Infectious Disease
Biomarker Testing Market, By Region:
- North-East
- Mid-West
- West
- South
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States infectious disease biomarker testing market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
Profit Margin Analysis
- Profit margin analysis in case of
direct and indirect sales channel.
It is an upcoming report to
be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at sales@techsciresearch.com
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com